CLINICAL_TRIALS
trial_result
· 2022-07-29
Clinical Trial Update: Assess the Ability of MetroGel 1% to Deliver Moisture to Facial Skin After a Single Application [Phase 4]
Summary
Phase 4 clinical trial assessing whether MetroGel 1% delivers moisture to facial skin after a single application in rosacea patients.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Galderma R&D | Conditions: Rosacea | Phase 4 | Status: COMPLETED